HIMS
Hims & Hers Health, Inc.
Price performance
Sep 18, 2026About
Company activity
35 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/10 | HIMS | 8-K | Hims & Hers Health Reports 38% Revenue Growth and Raises Guidance | — | — | — |
| 07/17 | HIMS | 8-K | Hims & Hers Health Announces Resignation of Chief Accounting Officer | — | — | — |
| 07/01 | HIMS | 8-K | Hims & Hers Health Enters into Receivables Purchase Agreement and Amends Credit Agreement | — | — | — |
| 06/15 | HIMS | 8-K | Hims & Hers Health Elects New Board Members at Annual Meeting | — | — | — |
| 06/02 | HIMS | 8-K | Hims & Hers Health Completes Acquisition of Eucalyptus | — | — | — |
| 05/21 | HIMS | 8-K | Hims & Hers Health, Inc. Issues $402.5 Million in Convertible Senior Notes | — | — | — |
| 05/19 | HIMS | 8-K | Hims & Hers Health Announces Convertible Senior Notes Offering | — | — | — |
| 05/11 | HIMS | 8-K | Hims & Hers Health Reports Q1 2026 Financial Results and Raises Guidance | — | — | — |
| 03/11 | HIMS | 8-K | Hims & Hers Health Announces Strategic Shift in U.S. Weight Loss Business | — | — | — |
| 02/23 | HIMS | 8-K | Hims & Hers Health Reports 59% YoY Revenue Growth in 2025 | — | — | — |
| 02/19 | HIMS | 8-K | Hims & Hers Announces Acquisition of Eucalyptus to Expand Global Footprint | — | — | — |
| 11/17/25 | HIMS | 8-K | Hims & Hers Health Announces New Share Repurchase Program | — | — | — |
| 11/03/25 | HIMS | 8-K | Hims & Hers Health Reports Strong Q3 2025 Financial Results and Updates Guidance | — | — | — |
| 10/02/25 | HIMS | 8-K | Hims & Hers Health Announces Leadership Transition | — | — | — |
| 09/22/25 | HIMS | 8-K | Hims & Hers Health Announces Public Information Channels | — | — | — |
| 09/05/25 | HIMS | 8-K | Hims & Hers Health Announces New Lease Agreement | — | — | — |
| 08/04/25 | HIMS | 8-K | Hims & Hers Health Reports Strong Q2 2025 Financial Results | — | — | — |
| 06/17/25 | HIMS | 8-K | Hims & Hers Health, Inc. Announces Stockholder Voting Results from Annual Meeting | — | — | — |
| 05/13/25 | HIMS | 8-K | Hims & Hers Health, Inc. Announces $1.0 Billion Convertible Senior Notes Issuance | — | — | — |
| 05/09/25 | HIMS | 8-K | Hims & Hers Health Announces $517.5M Convertible Senior Notes Offering | — | — | — |
| 05/05/25 | HIMS | 8-K | Hims & Hers Reports Strong Q1 2025 Financial Results and Raises Guidance | — | — | — |
| 04/21/25 | HIMS | 8-K | Hims & Hers Health Announces COO Transition | — | — | — |
| 02/24/25 | HIMS | 8-K | Hims & Hers Health Reports 69% YoY Revenue Growth in 2024 | — | — | — |
| 11/21/24 | HIMS | 8-K | Hims & Hers Health Appoints Deb Autor to Board of Directors | — | — | — |
| 11/04/24 | HIMS | 8-K | Hims & Hers Health Reports Strong Q3 2024 Results with 77% Revenue Growth | — | — | — |
| 09/09/24 | HIMS | 8-K | Hims & Hers Health, Inc. Files Prospectus Supplement for Acquisition Shares | — | — | — |
| 08/05/24 | HIMS | 8-K | Hims & Hers Health Reports Strong Q2 2024 Financial Results and Raises Guidance | — | — | — |
| 07/22/24 | HIMS | 8-K | Hims & Hers Health Appoints New Director | — | — | — |
| 06/10/24 | HIMS | 8-K | Hims & Hers Health, Inc. Announces Voting Results from Annual Meeting of Stockholders | — | — | — |
| 06/06/24 | HIMS | 8-K | Hims & Hers Health Appoints Anja Manuel to Board and Committees | — | — | — |
| 05/06/24 | HIMS | 8-K | Hims & Hers Health Reports 46% YoY Revenue Growth and Positive Net Income in Q1 2024 | — | — | — |
| 04/26/24 | HIMS | 8-K | Hims & Hers Health Appoints Anja Manuel to Board of Directors | — | — | — |
| 04/26/24 | HIMS | 8-K | Hims & Hers Health Appoints New Board Member and Committee Assignments | — | — | — |
| 04/03/24 | HIMS | 8-K | Hims & Hers Health Appoints New Board Member | — | — | — |
| 02/26/24 | HIMS | 8-K | Hims & Hers Health Reports Strong Q4 2023 Financial Results and Outlook | — | — | — |
HIMS filing record
Hims & Hers Health, Inc. (HIMS): 35 8-K filings summarized, the most recent on Aug 10, 2026.
What the 8-K filings said
- Aug 10, 2026 · high impact
Hims & Hers Health, Inc. reported a 38% year-over-year increase in revenue for the second quarter of 2026, reaching $753.2 million. The company also saw a 19% increase in subscribers, bringing the total to nearly 2.9 million. In response to these strong results, the company raised its full-year 2026 revenue guidance…
Hims & Hers Health Reports 38% Revenue Growth and Raises Guidance - Jul 17, 2026 · medium impact
Hims & Hers Health, Inc. announced on July 13, 2026, that Irene Becklund, its Chief Accounting Officer and Principal Accounting Officer, intends to resign from her positions effective October 9, 2026. Ms. Becklund has been with the company since April 2025 as Chief Accounting Officer and since November 2021 as…
Hims & Hers Health Announces Resignation of Chief Accounting Officer - Jul 1, 2026 · medium impact
Hims & Hers Health, Inc. has entered into a Master Receivables Purchase Agreement (RPA) with JPMorgan Chase Bank, N.A., allowing its subsidiaries to sell eligible receivables for cash. The company has also amended its existing Revolving Credit and Guaranty Agreement to permit the new financial arrangement. The…
Hims & Hers Health Enters into Receivables Purchase Agreement and Amends Credit Agreement - Jun 15, 2026 · high impact
Hims & Hers Health, Inc. held its Annual Meeting of Stockholders on June 11, 2026, where shareholders voted on three proposals. The key event was the election of nine directors to serve until the 2027 annual meeting. All directors were re-elected with significant support from shareholders. Additionally, shareholders…
Hims & Hers Health Elects New Board Members at Annual Meeting - Jun 2, 2026 · high impact
Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, a leading digital health company, enhancing its global footprint and reinforcing its position as the world's largest consumer health platform. The acquisition, which was facilitated by an amendment to the company's revolving credit and guaranty…
Hims & Hers Health Completes Acquisition of Eucalyptus
SEC filings in the last five years
- 41 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 2 Form 8-K/A